| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 6156 | 2005 |
| Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis … VJ Verwaal, S van Ruth, E de Bree, GW van Slooten, H van Tinteren, ... Journal of clinical oncology 21 (20), 3737-3743, 2003 | 2294 | 2003 |
| Hyperthermic intraperitoneal chemotherapy in ovarian cancer WJ Van Driel, SN Koole, K Sikorska, JH Schagen van Leeuwen, ... New England Journal of Medicine 378 (3), 230-240, 2018 | 1341 | 2018 |
| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 1229 | 2017 |
| 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of … VJ Verwaal, S Bruin, H Boot, G Van Slooten, H Van Tinteren Annals of surgical oncology 15, 2426-2432, 2008 | 1172 | 2008 |
| Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial H Van Tinteren, OS Hoekstra, EF Smit, JHAM Van Den Bergh, ... The Lancet 359 (9315), 1388-1392, 2002 | 1025 | 2002 |
| Risk of endometrial cancer after tamoxifen treatment of breast cancer FE van Leeuwen, AW Van den Belt-Dusebout, J Benraadt, ... The Lancet 343 (8895), 448-452, 1994 | 734 | 1994 |
| Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma CU Blank, EA Rozeman, LF Fanchi, K Sikorska, B van de Wiel, ... Nature medicine 24 (11), 1655-1661, 2018 | 711 | 2018 |
| Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019 | 702 | 2019 |
| Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial JB Vermorken, AME Claessen, H Van Tinteren, HE Gall, R Ezinga, ... The Lancet 353 (9150), 345-350, 1999 | 624 | 1999 |
| Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial BJ Slotman, H van Tinteren, JO Praag, JL Knegjens, SY El Sharouni, ... The Lancet 385 (9962), 36-42, 2015 | 585 | 2015 |
| Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group LHJ Simkens, H van Tinteren, A May, AJ ten Tije, GJM Creemers, ... The Lancet 385 (9980), 1843-1852, 2015 | 556 | 2015 |
| Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials Prostate Cancer Trialists Collaborative Group The Lancet 355 (9214), 1491-1498, 2000 | 541 | 2000 |
| EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer N Van Zandwijk, O Dalesio, U Pastorino, N de Vries, H van Tinteren Journal of the National Cancer Institute 92 (12), 977-986, 2000 | 478 | 2000 |
| Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial A Cats, EPM Jansen, NCT van Grieken, K Sikorska, P Lind, M Nordsmark, ... The lancet oncology 19 (5), 616-628, 2018 | 474 | 2018 |
| Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure M Donker, ME Straver, J Wesseling, CE Loo, M Schot, CA Drukker, ... Annals of surgery 261 (2), 378-382, 2015 | 422 | 2015 |
| Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2 … EA Rozeman, AM Menzies, ACJ van Akkooi, C Adhikari, C Bierman, ... The Lancet Oncology 20 (7), 948-960, 2019 | 419 | 2019 |
| Clinical prediction model to characterize pulmonary nodules: validation and added value of 18 F-fluorodeoxyglucose positron emission tomography GJ Herder, H Van Tinteren, RP Golding, PJ Kostense, EF Comans, ... Chest 128 (4), 2490-2496, 2005 | 415 | 2005 |
| A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution's experience with consistent application of provox indwelling voice prostheses BMRO de Coul, FJM Hilgers, AJM Balm, IB Tan, FJA Van den Hoogen, ... Archives of Otolaryngology–Head & Neck Surgery 126 (11), 1320-1328, 2000 | 364 | 2000 |
| Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma S Kelderman, B Heemskerk, H Van Tinteren, RRH Van Den Brom, ... Cancer Immunology, Immunotherapy 63, 449-458, 2014 | 363 | 2014 |
